Indian Market

Investors File Plea in Delhi HC Urging Sebi to Approve NSE IPO

Investors File Plea in Delhi HC Urging Sebi to Approve NSE IPO

/ Indian Market /

Investors, led by the People Activism Forum, have petitioned the Delhi High Court to direct the Securities and Exchange Board of India (Sebi) to approve the National Stock Exchange’s (NSE) long-awaited initial public offering (IPO). The plea follows Sebi’s reluctance to issue a no-objection certificate (NOC) despite NSE reapplying on August 27, according to a […]

Investors File Plea in Delhi HC Urging Sebi to Approve NSE IPO Read More »

Flipkart Plans IPO by 2026, Shifts Base to India for Domestic Listing: Report

Flipkart Plans IPO by 2026, Shifts Base to India for Domestic Listing: Report

/ Indian Market /

Flipkart, India’s leading e-commerce platform, is preparing for an initial public offering (IPO) in the next 12-15 months, with plans to shift its corporate domicile from Singapore to India, according to reports. The Walmart-owned company, valued at $36 billion, has reportedly secured internal approvals for this strategic move, which aligns with its vision to list

Flipkart Plans IPO by 2026, Shifts Base to India for Domestic Listing: Report Read More »

Paytm Singapore to Sell Stock Acquisition Rights in PayPay for ₹2,364 Crore

Paytm Singapore to Sell Stock Acquisition Rights in PayPay for ₹2,364 Crore

/ Indian Market /

Paytm’s wholly-owned subsidiary, One97 Communications Singapore Pvt Ltd (Paytm Singapore), announced the sale of its Stock Acquisition Rights (SARs) in Japan’s PayPay Corporation to SoftBank Vision Fund 2. The deal, valued at ¥41.9 billion (approximately ₹2,364 crore), is expected to conclude by December 2024, pending corporate approvals and other customary conditions. Deal Highlights Paytm’s Continued

Paytm Singapore to Sell Stock Acquisition Rights in PayPay for ₹2,364 Crore Read More »

Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million

Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million

/ Indian Market /

Hyderabad-based Suven Pharmaceuticals has entered into definitive agreements to acquire a 56% equity stake in NJ Bio, Inc., a Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Princeton, New Jersey. The $64.4 million transaction comprises a mix of primary equity infusion and secondary share acquisition. Key Details of the Acquisition NJ Bio is a

Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million Read More »

Bajaj Healthcare Secures Australian TGA Approval for Gujarat API Site

Bajaj Healthcare Secures Australian TGA Approval for Gujarat API Site

/ Indian Market /

Bajaj Healthcare’s manufacturing facility in Savli, Vadodara, Gujarat, has received approval from Australia’s Therapeutic Goods Administration (TGA). This achievement enhances its global credentials and allows direct supply of active pharmaceutical ingredients (APIs) to Australian and New Zealand markets. Already approved by the USFDA and the European Union, this latest certification is valid for 24 months.

Bajaj Healthcare Secures Australian TGA Approval for Gujarat API Site Read More »

IMF’s Krishnamurthy Subramanian Says: 'The world is bullish on India'

IMF’s Krishnamurthy Subramanian Says: ‘The world is bullish on India’

/ Indian Market /

Krishnamurthy V Subramanian, India’s top economist and Executive Director at the International Monetary Fund (IMF), highlighted the growing global confidence in India’s economic future. In an interview, he praised India’s public digital infrastructure and its focus on inclusive growth. Subramanian noted India’s steady post-COVID growth rate of 7%, despite recent slowdowns due to reduced capital

IMF’s Krishnamurthy Subramanian Says: ‘The world is bullish on India’ Read More »

Jupiter India Fund Offloads 0.5% Stake in Himatsingka Seide

Jupiter India Fund Offloads 0.5% Stake in Himatsingka Seide, Bulk Deals Highlight Market Action

/ Indian Market /

On December 6, The Royal Bank of Scotland Plc, acting as Trustee for Jupiter India Fund, sold a 0.5% stake in Himatsingka Seide at an average price of Rs 195.22 per share. This transaction, valued at Rs 13.48 crore, reduced the fund’s stake, which stood at 5.01% as of October 2024. Despite the sale, shares

Jupiter India Fund Offloads 0.5% Stake in Himatsingka Seide, Bulk Deals Highlight Market Action Read More »

RITES Shares Gain 5% on Winning Rs 148.25 Crore IIM Raipur Contract

RITES Shares Gain 5% on Winning Rs 148.25 Crore IIM Raipur Contract

/ Indian Market /

Shares of RITES Limited rose nearly 5% in early trade on December 6 after the company announced that it has secured a Rs 148.25 crore project from the Indian Institute of Management (IIM) Raipur. The project involves RITES acting as the Project Management Consultant for the Phase II development of the institute’s campus in Chhattisgarh.

RITES Shares Gain 5% on Winning Rs 148.25 Crore IIM Raipur Contract Read More »

RBI Keeps Repo Rate Steady at 6.5% for the 11th Consecutive Time

RBI Keeps Repo Rate Steady at 6.5% for the 11th Consecutive Time

/ Indian Market /

The Reserve Bank of India’s (RBI) Monetary Policy Committee (MPC) announced on December 6 that the repo rate would remain unchanged at 6.5%, marking the 11th consecutive decision to maintain the rate. Key Highlights Economic Context This was pretty much expected from the latest Moneycontrol survey of 17 economists, bankers, and fund managers. Unchanged rates

RBI Keeps Repo Rate Steady at 6.5% for the 11th Consecutive Time Read More »

Mobikwik IPO Price Band Announced at Rs 265-279; Size Reduced to Rs 572 Crore

Mobikwik IPO Price Band Announced at Rs 265-279; Size Reduced to Rs 572 Crore

/ Indian Market /

Digital payments platform One Mobikwik Systems Ltd has set the price band for its upcoming IPO at Rs 265-279 per share, with the public subscription scheduled from December 11 to 13. Anchor investors can bid starting December 10. The IPO size has been trimmed for the third time, now targeting Rs 572 crore, compared to

Mobikwik IPO Price Band Announced at Rs 265-279; Size Reduced to Rs 572 Crore Read More »

Scroll to Top